Corticosteroids and Post-ERCP Pancreatitis
Author Information
Author(s): Zheng Minghua, Bai Jianling, Yuan Bosi, Lin Feng, You Jie, Lu Mingqin, Gong Yuewen, Chen Yongping
Primary Institution: The First Affiliated Hospital of Wenzhou Medical College
Hypothesis
Does prophylactic use of corticosteroids reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis?
Conclusion
Corticosteroids cannot prevent pancreatic injury after ERCP, so their use in prophylaxis of post-ERCP pancreatitis is not recommended.
Supporting Evidence
- The meta-analysis included seven high-quality randomized controlled trials.
- Corticosteroids showed no significant reduction in the incidence of post-ERCP pancreatitis.
- The odds ratio for corticosteroid use was 1.13, indicating no beneficial effect.
Takeaway
The study found that giving corticosteroids before a procedure to prevent pancreatitis doesn't work, so doctors shouldn't use them for this purpose.
Methodology
A meta-analysis of seven randomized controlled trials was conducted to evaluate the effectiveness and safety of corticosteroids in preventing post-ERCP pancreatitis.
Potential Biases
No evidence of publication bias was found.
Limitations
The studies included varied in design, dosage, and timing of corticosteroid administration, which may affect the results.
Participant Demographics
Patients scheduled to undergo ERCP, aged over 18 years.
Statistical Information
P-Value
0.32
Confidence Interval
95% CI (0.89~1.44)
Statistical Significance
p=0.32
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website